Guillain-Barre syndrome and influenza vaccines: a meta-analysis.
Abstract
Cases of Guillain-Barré syndrome (GBS) have been occasionally associated with influenza vaccines; this possible risk, even if rare, is a matter of much concern. To investigate the strength of this association, a systematic review and a meta-analysis have been conducted; for the purpose, controlled observational studies addressing the risk of GBS associated with different influenza vaccines were sought. We finally selected 39 studies of interest published between 1981 and 2014 (seasonal influenza vaccines, 22; pandemic influenza vaccines, 16; both vaccines simultaneously administered, 1); funnel plot did not identify publication bias. At the association between any influenza vaccine - whether seasonal or pandemic - with GBS, the overall relative risk was 1.41 (95% CI, 1.20-1.66). Pandemic vaccines presented a higher risk (RR=1.84; 95% CI, 1.36-2.50) compared to seasonal vaccines (RR=1.22; 95% CI, 1.01-1.48); the latter should be considered as marginally statistically significant. Pandemic adjuvanted vaccines were not found to be related to a higher risk compared to non-adjuvanted vaccines. The results of the present meta-analysis point to a small but statistically significant association between influenza vaccines, particularly the pandemic ones, and GBS, which is consistent with current explanations upon possible mechanisms for this condition to appear.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A meta-analysis of 39 controlled observational studies found that the relative risk of Guillain-Barré syndrome following receipt of any influenza vaccine was 1.41.
“A metanalysis of 39 controlled observational studies found that the relative risk of GBS following receipt of any influenza vaccine was 1.41 (Martin Arias et al., 2015).”
From Vaccine Safety: Myths and Misinformation (2020) · cites this paper as Martin Arias et al., 2015
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · see citing works
Liberati, A., Altman, D. G., Tetzlaff, J., Mulrow, C., Gøtzsche, P. C., Ioannidis, J. P. A., Clarke, M., Devereaux, P. J., Kleijnen, J., & Moher, D. (2009) · PLoS Medicine · doi:10.1371/journal.pmed.1000100 · Cited by 28,164 · see citing works
Yuki, N., & Hartung, H. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1114525 · Cited by 1,270 · see citing works
Population Incidence of Guillain-Barré Syndrome: A Systematic Review and Meta-Analysis
Sejvar, J. J., Baughman, A. L., Wise, M. P., & Morgan, O. W. (2011) · Neuroepidemiology · doi:10.1159/000324710 · Cited by 959 · see citing works
Schonberger, L. B., Bregman, D. J., SULLIVAN-BOLYAI, J. Z., Keenlyside, R. A., Ziegler, D. W., RETAILLIAU, H. F., EDDINS, D. L., & Bryan, J. A. (1979) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a112795 · Cited by 784 · see citing works
Tutorial in biostatistics: the self‐controlled case series method
Whitaker, H. J., Paddy Farrington, C., Spiessens, B., & Musonda, P. (2006) · Statistics in Medicine · doi:10.1002/sim.2302 · Cited by 719 · see citing works
The Guillain–Barré Syndrome and the 1992–1993 and 1993–1994 Influenza Vaccines
Lasky, T., Terracciano, G. J., Magder, L. S., Koski, C. L., Ballesteros, M., Nash, D., Clark, S., Haber, P., Stolley, P. D., Schonberger, L. B., et al. (1998) · New England Journal of Medicine · doi:10.1056/nejm199812173392501 · Cited by 501 · see citing works
Vaccines and Guillain-Barré Syndrome
Haber, P., Sejvar, J. J., Mikaeloff, Y., & Destefano, F. R. (2009) · Drug Safety · doi:10.2165/00002018-200932040-00005 · Cited by 235 · see citing works
Salmon, D. A., Proschan, M. A., Forshee, R. A., Gargiullo, P. M., Bleser, W. K., Burwen, D. R., Cunningham, F. E., Garman, P. M., Greene, S. K., Lee, G. M., et al. (2013) · The Lancet · doi:10.1016/s0140-6736(12)62189-8 · Cited by 212 · see citing works
Guillain-Barré Syndrome After Influenza Vaccination in Adults
Juurlink, D. N. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.20.2217 · Cited by 201 · see citing works
Guillain-Barré syndrome after exposure to influenza virus
Lehmann, H. C., Hartung, H., Kieseier, B. C., & Hughes, R. A. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70140-7 · Cited by 199 · see citing works
Tam, C. C., O’Brien, S. J., Petersen, I., Islam, A., Hayward, A. C., & Rodrigues, L. C. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000344 · Cited by 193 · see citing works
Stowe, J., Andrews, N. J., Wise, L., & Miller, E. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn310 · Cited by 192 · see citing works
Vellozzi, C., Burwen, D. R., Dobardzic, A., Ball, R., Walton, K., & Haber, P. (2009) · Vaccine · doi:10.1016/j.vaccine.2009.01.125 · Cited by 188 · see citing works
Guillain-Barré Syndrome and the 1978–1979 Influenza Vaccine
Hurwitz, E. S., Schonberger, L. B., Nelson, D. B., & Holman, R. C. (1981) · New England Journal of Medicine · doi:10.1056/nejm198106253042601 · Cited by 176 · see citing works
Kaplan, J. (1982) · JAMA · doi:10.1001/jama.248.6.698 · Cited by 176 · see citing works
Dieleman, J. P., Romio, S., Johansen, K., Weibel, D. M., Bonhoeffer, J., Sturkenboom, M., & and the VAESCO-GBS Case-Control Study Group (2011) · BMJ · doi:10.1136/bmj.d3908 · Cited by 175 · see citing works
Waddington, C. S., Walker, W. T., Oeser, C., Reiner, A., John, T. M., Wilkins, S., Casey, M., Eccleston, P., Allen, R., Okike, I. O., et al. (2010) · BMJ · doi:10.1136/bmj.c2649 · Cited by 161 · see citing works
Guillain-Barré Syndrome in the United States, 1979-1980 and 1980-1981
Kaplan, J. E. (1982) · JAMA · doi:10.1001/jama.1982.03330060038030 · Cited by 125 · see citing works
Kwong, J. C., Vasa, P. P., Campitelli, M. A., Hawken, S., Wilson, K., Rosella, L. C., Stukel, T. A., Crowcroft, N. S., McGeer, A. J., Zinman, L., et al. (2013) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70104-x · Cited by 115 · see citing works
Nachamkin, I., Shadomy, S. V., Moran, A. P., Cox, N., Fitzgerald, C., Ung, H., Corcoran, A. T., Iskander, J. K., Schonberger, L. B., & Chen, R. T. (2008) · The Journal of Infectious Diseases · doi:10.1086/589624 · Cited by 113 · see citing works
Dodd, C. N., Romio, S., BLACK, S. B., Vellozzi, C. J., Andrews, N. J., Sturkenboom, M., ZUBER, P. L. F., Hua, W., Bonhoeffer, J., Buttery, J. P., et al. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.06.032 · Cited by 109 · see citing works
Lack of Association of Guillain-Barre Syndrome With Vaccinations
Baxter, R. P., Bakshi, N., FIREMAN, B. H., Lewis, E. M., Ray, P., Vellozzi, C. J., & Klein, N. P. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit222 · Cited by 109 · see citing works
Prothro, C., Kudish, K. S., Fielline, M., Meek, J. I., Tellman, N., Milewski, M., Hogan, B. C., Holtzman, C., Danila, R., DUNNING, L. H., et al. (2010) · PubMed · Cited by 108 · see citing works
No Association Between Immunization and Guillain-Barré Syndrome in the United Kingdom, 1992 to 2000
Hughes, R. A., Charlton, J., Latinovic, R., & Gulliford, M. C. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.12.1301 · Cited by 100 · see citing works
Wise, M. E., Viray, M. A., Sejvar, J. J., Lewis, P., Baughman, A. L., Connor, W., Danila, R., Giambrone, G. P., Hale, C. R., Hogan, B., et al. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws196 · Cited by 94 · see citing works
Greene, S. K., Rett, M., Weintraub, E. S., Li, L., Yin, R., Amato, A. A., Ho, D. T., Sheikh, S. I., Fireman, B. H., Daley, M. F., et al. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws195 · Cited by 91 · see citing works
Risk of Guillain-Barré Syndrome Following H1N1 Influenza Vaccination in Quebec
Wals, P. D., Deceuninck, G., Toth, E., Boulianne, N., Brunet, D., Boucher, R., Landry, M., & Serres, G. D. (2012) · JAMA · doi:10.1001/jama.2012.7342 · Cited by 85 · see citing works
Grimaldi‐Bensouda, L., Alpérovitch, A., Besson, G., Vial, C., Cuisset, J., Papeix, C., Lyon‐Caen, O., Bénichou, J., Rossignol, M., & Lucien Abenhaim for the GBS-PGRx Study Group (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr072 · Cited by 76 · see citing works
Yih, W. K., Lee, G. M., Lieu, T. A., Ball, R., Kulldorff, M., Rett, M. D., Wahl, P. M., McMahill‐Walraven, C. N., Platt, R. G., & Salmon, D. A. (2012) · American Journal of Epidemiology · doi:10.1093/aje/kws197 · Cited by 71 · see citing works
Guillain-Barré Syndrome Incidence in a Large United States Cohort (2000–2009)
Shui, I. M., Rett, M. D., Weintraub, E., Marcy, M., Amato, A. A., Sheikh, S. I., Ho, D. T., Lee, G. M., & Yih, W. K. (2012) · Neuroepidemiology · doi:10.1159/000339248 · Cited by 70 · see citing works
Blum, S., & McCombe, P. (2014) · Journal of the Peripheral Nervous System · doi:10.1111/jns5.12074 · Cited by 66 · see citing works
Guillain-Barré Syndrome: Modern Theories of Etiology
Hardy, T. A., Blum, S., McCombe, P., & Reddel, S. (2011) · Current Allergy and Asthma Reports · doi:10.1007/s11882-011-0190-y · Cited by 63 · see citing works
Romio, S., Weibel, D. M., Dieleman, J. P., Olberg, H. K., de Vries, C. S., Sammon, C., Andrews, N. J., Svanström, H., Mølgaard‐Nielsen, D., Hviid, A. P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0082222 · Cited by 59 · see citing works
Greene, S. K., Rett, M. D., Vellozzi, C., Li, L., Kulldorff, M., Marcy, S. M., Daley, M. F., Belongia, E. A., Baxter, R., Fireman, B. H., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0067185 · Cited by 59 · see citing works
Evaluation of Guillain-Barré Syndrome Among Recipients of Influenza Vaccine in 2000 and 2001
Burwen, D. R., Ball, R., Bryan, W. W., Izurieta, H. S., Voie, L. L., Gibbs, N. A., Kliman, R. E., & Braun, M. M. (2010) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2010.05.022 · Cited by 56 · see citing works
Tokars, J. I., Lewis, P., Destefano, F. R., Wise, M. E., Viray, M. A., Morgan, O. W., Gargiullo, P. M., & Vellozzi, C. J. (2012) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3220 · Cited by 54 · see citing works
Kawai, A. T., Li, L., Kulldorff, M., Vellozzi, C. J., Weintraub, E., Baxter, R. P., Belongia, E. A., Daley, M. F., Jacobsen, S. J., Naleway, A. L., et al. (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3575 · Cited by 53 · see citing works
Isai, A., Durand, J., Meur, S. L., Hidalgo‐Simon, A., & Kurz, X. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.09.032 · Cited by 53 · see citing works
Tam, C. C., O’Brien, S. J., & Rodrigues, L. C. (2006) · Emerging infectious diseases · doi:10.3201/eid1212.051032 · Cited by 51 · see citing works
Risk of Guillain-Barré syndrome after 2010–2011 influenza vaccination
The ITANG study group, Galeotti, F., Massari, M., D’Alessandro, R., Beghi, E., Chiò, A., Logroscino, G., Filippini, G., Benedetti, M. D., Pugliatti, M., et al. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9797-8 · Cited by 49 · see citing works
Vellozzi, C. J., Iqbal, S., Stewart, B., Tokars, J. I., & Destefano, F. R. (2014) · American Journal of Public Health · doi:10.2105/ajph.2013.301651 · Cited by 48 · see citing works
Andrews, N. J., Stowe, J., Salman, R. A., & Miller, E. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.08.069 · Cited by 47 · see citing works
Polakowski, L., Sandhu, S. K., Martin, D. B., Ball, R., MaCurdy, T. E., Franks, R. L., Gibbs, J. M., Kropp, G., Avagyan, A., Kelman, J. A., et al. (2013) · American Journal of Epidemiology · doi:10.1093/aje/kwt051 · Cited by 40 · see citing works
Guillain-Barre Syndrome Associated with Campylobacter jejuni Infection in England, 2000-2001
Tam, C. C., Rodrigues, L. C., & O’Brien, S. J. (2003) · Clinical Infectious Diseases · doi:10.1086/375845 · Cited by 36 · see citing works
Risk of Guillain–Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany
Prestel, J., Volkers, P., Mentzer, D., Lehmann, H. C., Hartung, H., Keller‐Stanislawski, B., & for the GBS Study Group (2014) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3638 · Cited by 35 · see citing works
Crawford, N. W., Cheng, A., Andrews, N. J., Charles, P. G. P., Clothier, H. J., Day, B. J., Day, T., Gates, P., Macdonell, R. A. L., Roberts, L. J., et al. (2012) · The Medical Journal of Australia · doi:10.5694/mja12.10534 · Cited by 32 · see citing works
Guillain-Barré Syndrome Following Influenza Vaccination: Causal or Coincidental?
Sejvar, J. J., Pfeifer, D., & Schonberger, L. B. (2011) · Current Infectious Disease Reports · doi:10.1007/s11908-011-0194-8 · Cited by 30 · see citing works
Hoshino, T., Uchiyama, Y., Ito, E., Osawa, S., & Ohashi, T. (2012) · Internal Medicine · doi:10.2169/internalmedicine.51.7132 · Cited by 26 · see citing works
Evaluating the safety of influenza vaccine using a claims-based health system
McCarthy, N. L., Gee, J. M., Lin, N. D., Hoffman, V., Pan, Y., Su, S., Turnbull, B., Chan, K. A., & Weintraub, E. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.10.031 · Cited by 23 · see citing works
Safety of Pandemic (H1N1) 2009 Monovalent Vaccines in Taiwan: A Self-Controlled Case Series Study
Huang, W., Yang, H.-W., Liao, T.-L., Wu, W.-J., Yang, S.-E., Chih, Y.-C., & Chuang, J.-H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058827 · Cited by 23 · see citing works
McGarvey, P. B., Süzek, B. E., Baraniuk, J. N., Rao, S., Conkright, B., Lababidi, S., Sutherland, A., Forshee, R. A., & Madhavan, S. (2014) · BMC Immunology · doi:10.1186/s12865-014-0061-0 · Cited by 22 · see citing works
Lei, T., Siu, K., Kok, K., Chan, K., Chan, E. Y. T., Hung, I. F., To, K. K., Li, P. C., Zhou, J., Zheng, B., et al. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.02.009 · Cited by 15 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Walter, E. B., Fry, A. M., & Jernigan, D. B. (2018) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr6703a1 · Cited by 1,635 · see citing works
Prevention and Control of Seasonal Influenza with Vaccines
Grohskopf, L. A., Sokolow, L. Z., Broder, K. R., Olsen, S. J., Karron, R. A., Jernigan, D. B., & Bresee, J. (2016) · MMWR Recommendations and Reports · doi:10.15585/mmwr.rr6505a1 · Cited by 597 · see citing works
Vaccine Safety: Myths and Misinformation
Geoghegan, S., O’Callaghan, K. P., & Offit, P. A. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00372 · Cited by 275 · see citing works
van Doorn, P. A., den Bergh, P. Y. K. V., Hadden, R. D. M., Avau, B., Vankrunkelsven, P., Attarian, S., Blomkwist‐Markens, P. H., Cornblath, D. R., Goedee, H. S., Harbo, T., et al. (2023) · European Journal of Neurology · doi:10.1111/ene.16073 · Cited by 261 · see citing works
Kieseier, B. C., Mathey, E. K., Sommer, C., & Hartung, H. (2018) · Nature Reviews Disease Primers · doi:10.1038/s41572-018-0027-2 · Cited by 155 · see citing works
Autoimmune/inflammatory syndrome induced by adjuvants (Shoenfeld’s syndrome) – An update
Watad, ., Quaresma, M., Brown, S., Tervaert, J. W. C., Rodríguez‐Pintó, I., Cervera, R., Perricone, C., & Shoenfeld, Y. (2017) · Lupus · doi:10.1177/0961203316686406 · Cited by 150 · see citing works
Esposito, S., & Longo, M. R. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.09.022 · Cited by 150 · see citing works
Vaccinations and Autoimmune Diseases
Olivieri, B., Betterle, C., & Zanoni, G. (2021) · Vaccines · doi:10.3390/vaccines9080815 · Cited by 118 · see citing works
van Doorn, P. A., den Bergh, P. Y. K. V., Hadden, R. D. M., Avau, B., Vankrunkelsven, P., Attarian, S., Blomkwist‐Markens, P. H., Cornblath, D. R., Goedee, H. S., Harbo, T., et al. (2023) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12594 · Cited by 113 · see citing works
The state of vaccine safety science: systematic reviews of the evidence
Dudley, M. Z., Halsey, N. A., Omer, S. B., Orenstein, W. A., O’Leary, S. T., Limaye, R. J., & Salmon, D. A. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30130-4 · Cited by 99 · see citing works
Principal Controversies in Vaccine Safety in the United States
DeStefano, F., Bodenstab, H. M., & Offit, P. A. (2019) · Clinical Infectious Diseases · doi:10.1093/cid/ciz135 · Cited by 86 · see citing works
Influenza vaccines: Evaluation of the safety profile
Trombetta, C. M., Gianchecchi, E., & Montomoli, E. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1423153 · Cited by 85 · see citing works
Uyeki, T. M. (2017) · Annals of Internal Medicine · doi:10.7326/aitc201709050 · Cited by 84 · see citing works
Kondrich, J., & Rosenthal, M. (2017) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000495 · Cited by 68 · see citing works
Vaccines and the risk of Guillain-Barré syndrome
Chen, Y., Zhang, J., Chu, X., Xu, Y., & Ma, F. (2019) · European Journal of Epidemiology · doi:10.1007/s10654-019-00596-1 · Cited by 61 · see citing works
Wachira, V. K., Peixoto, H. M., & de Oliveira, M. R. F. (2018) · Tropical Medicine & International Health · doi:10.1111/tmi.13181 · Cited by 60 · see citing works
Guillain-Barré syndrome following BNT162b2 COVID-19 vaccine
Trimboli, M., Zoleo, P., Arabia, G., & Gambardella, A. (2021) · Neurological Sciences · doi:10.1007/s10072-021-05523-5 · Cited by 58 · see citing works
Rate of Recurrent Guillain-Barré Syndrome After mRNA COVID-19 Vaccine BNT162b2
David, S. S. B., Potasman, I., & Rahamim‐Cohen, D. (2021) · JAMA Neurology · doi:10.1001/jamaneurol.2021.3287 · Cited by 50 · see citing works
Uyeki, T. M. (2021) · Annals of Internal Medicine · doi:10.7326/aitc202111160 · Cited by 46 · see citing works
The Impacts of Influenza Infection and Vaccination on Exacerbation of Myasthenia Gravis
Seok, H. Y., Shin, H. Y., Kim, J. K., Kim, B., Oh, J., Suh, B. C., Kim, S., Kang, S., Ahn, S.-W., Bae, J. S., et al. (2017) · Journal of Clinical Neurology · doi:10.3988/jcn.2017.13.4.325 · Cited by 42 · see citing works
Lau, J., Nettifee, J. A., Early, P. J., Mariani, C. L., Olby, N. J., & Muñana, K. R. (2019) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.15543 · Cited by 42 · see citing works
Prasad, A., Hurlburt, G. A., Podury, S., Tandon, M., Kingree, S., & Sriwastava, S. (2021) · Neurology International · doi:10.3390/neurolint13030040 · Cited by 41 · see citing works
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): past, present, and future implications
Seida, I., Alrais, M., Seida, R., Alwani, A., Kiyak, Z., Elsalti, A., Esirgün, S. N., Abali, T., & Mahroum, N. (2023) · Clinical & Experimental Immunology · doi:10.1093/cei/uxad033 · Cited by 41 · see citing works
Fragoso, Y. D., Gomes, S., Gonçalves, M. V. M., Júnior, E. M., de Oliveira, B. E. S., Rocha, C. F., dos Santos, G. A. C., Tauil, C. B., Araujo, R. V., & Peron, J. P. S. (2021) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2021.103321 · Cited by 38 · see citing works
RetractedTo be, or not to be… Guillain-Barré Syndrome
Florian, I. A., Lupan, I., Sur, L. M., Samaşcă, G., & Timiș, T. L. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2021.102983 · Cited by 36 · see citing works
Seasonal influenza vaccine and Guillain-Barré syndrome
Grave, C., Boucheron, P., Rudant, J., Mikaeloff, Y., Tubert‐Bitter, P., Escolano, S., Hocine, M. N., Coste, J., & Weill, A. (2020) · Neurology · doi:10.1212/wnl.0000000000009180 · Cited by 33 · see citing works
Sansone, G., & Bonifati, D. M. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11140-9 · Cited by 33 · see citing works
The science of vaccine safety: Summary of meeting at Wellcome Trust
Plotkin, S. A., Offit, P. A., Destefano, F. R., Larson, H. J., Arora, N. K., ZUBER, P. L. F., Fombonne, E. J., Sejvar, J. J., Lambert, P. H., Hviid, A. P., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.01.024 · Cited by 29 · see citing works
Maréchal, M. L., Fressard, L., Agrinier, N., Verger, P., & Pulcini, C. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.10.021 · Cited by 28 · see citing works
Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews
Juvet, L. K., Robertson, A. H., Laake, I., Mjaaland, S., & Trogstad, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.740048 · Cited by 28 · see citing works
Global burden of vaccine-associated Guillain-Barré syndrome over 170 countries from 1967 to 2023
Jeong, Y. D., Park, S., Lee, S., Jang, W., Park, J., Lee, K., Lee, J., Kang, J., Udeh, R., Rahmati, M., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-74729-2 · Cited by 27 · see citing works
Adverse events following immunization: real causality and myths
Principi, N., & Esposito, S. (2016) · Expert Opinion on Drug Safety · doi:10.1517/14740338.2016.1167869 · Cited by 26 · see citing works
Presumed Unilateral Acute Idiopathic Maculopathy following H1N1 Vaccination
Jorge, L. F., Queiroz, R. D. P., Gasparin, F., & Vasconcelos-Santos, D. V. (2020) · Ocular Immunology and Inflammation · doi:10.1080/09273948.2020.1734213 · Cited by 26 · see citing works
Petráš, M., Lesná, I. K., Dáňová, J., & Čelko, A. M. (2020) · Vaccines · doi:10.3390/vaccines8020150 · Cited by 26 · see citing works
de Souza, A., Oo, W. M., & Giri, P. (2022) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2022.120231 · Cited by 26 · see citing works
Vaccines and Autoimmunity—From Side Effects to ASIA Syndrome
Seida, I., Seida, R., Elsalti, A., & Mahroum, N. (2023) · Medicina · doi:10.3390/medicina59020364 · Cited by 24 · see citing works
Haber, P., Moro, P. L., Ng, C. S., Dores, G. M., Lewis, P., & Cano, M. V. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.01.052 · Cited by 23 · see citing works
Clinical Features of Post-Vaccination Guillain-Barré Syndrome (GBS) in Korea
Park, Y.-S., Lee, K., Kim, S. W., Kim, K. M., & Suh, B. C. (2017) · Journal of Korean Medical Science · doi:10.3346/jkms.2017.32.7.1154 · Cited by 22 · see citing works
Levison, L. S., Thomsen, R. W., & Andersen, H. (2022) · European Journal of Neurology · doi:10.1111/ene.15516 · Cited by 20 · see citing works
Spanish GBS Epidemiology Study Group, Alcalde-Cabero, E., Almazán‐Isla, J., López, F. J. G., Ara, J. R., Avellanal, F., Casasnovas, C., Cemillán, C. A., Cuadrado, J. I., Duarte, J., et al. (2016) · BMC Neurology · doi:10.1186/s12883-016-0598-z · Cited by 20 · see citing works
Garcia-Grimshaw, M. A., Galnares‐Olalde, J. A., Bello‐Chavolla, O. Y., Michel‐Chávez, A., Cadena‐Fernández, A., Briseño‐Godínez, M. E., Antonio‐Villa, N. E., Núñez, I., Gutiérrez, A., Hernández‐Vanegas, L. E., et al. (2022) · European Journal of Neurology · doi:10.1111/ene.15504 · Cited by 19 · see citing works
Guillain-Barré syndrome and influenza vaccines: current evidence.
Fadrique, R. S., Arias, L. M., Molina-Güarneros, J., Bulnes, N. J., & Ortega, P. G. (2019) · PubMed Central · Cited by 19 · see citing works
Ha, J., Park, S., Kang, H., Kyung, T., Kim, N., Kim, D., Kim, H., Bae, K., Song, M. C., Lee, K. J., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-30940-1 · Cited by 18 · see citing works
Stowe, J., Andrews, N. J., & Miller, E. (2019) · CNS Drugs · doi:10.1007/s40263-019-00670-y · Cited by 18 · see citing works
Respiratory virus-induced heterologous immunity
Pusch, E., Renz, H. E., & Skevaki, C. L. (2018) · Allergo Journal International · doi:10.1007/s40629-018-0056-0 · Cited by 18 · see citing works
Michaelson, N. M., Lam, T., Malhotra, A., Schiff, N. D., & MacGowan, D. J. L. (2021) · Journal of Clinical Neuromuscular Disease · doi:10.1097/cnd.0000000000000376 · Cited by 16 · see citing works
Gobert, C., Semaille, P., Schueren, T. V. D., Verger, P., & Dauby, N. (2021) · Vaccines · doi:10.3390/vaccines9070771 · Cited by 16 · see citing works
Ling, L., Bagshaw, S. M., & Villeneuve, P.-M. (2021) · Canadian Medical Association Journal · doi:10.1503/cmaj.210947 · Cited by 16 · see citing works
Nasreen, S., Jiang, Y., Han, L., Lee, A. C.-L., Cutland, C., de Gentile, A. S., Giglio, N., Macartney, K. K., Deng, L., Liu, B. C., et al. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127291 · Cited by 15 · see citing works
Doneddu, P. E., Spina, E., Briani, C., Fabrizi, G. M., Manganelli, F., & Nobile‐Orazio, E. (2021) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12435 · Cited by 15 · see citing works
de Lusignan, S., Santos, G. D., Byford, R. C., Schuind, A., Damaso, S., Shende, V. H., McGee, C., Yonova, I., & Ferreira, F. M. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0747-4 · Cited by 14 · see citing works
A Rare Variant of Guillain-Barre Syndrome Following Ad26.COV2.S Vaccination
Morehouse, Z. P., Paulus, A., Jasti, S. A., & Bing, X. (2021) · Cureus · doi:10.7759/cureus.18153 · Cited by 14 · see citing works
Frequently asked questions on seven rare adverse events following immunization
D’Alò, G. L., Zorzoli, E., Capanna, A., Gervasi, G., Terracciano, E., Zaratti, L., & Franco, E. (2016) · Journal of preventive medicine and hygiene · doi:10.15167/2421-4248/jpmh2017.58.1.659 · Cited by 14 · see citing works
Gallo, K., Goede, A., Mura, C., Abel, R., Moahamed, B., Preißner, S., Nahles, S., Heiland, M., Bourne, P. E., Preißner, R., et al. (2022) · Vaccines · doi:10.3390/vaccines10030408 · Cited by 13 · see citing works
Respiratory virus-induced heterologous immunity
Pusch, E., Renz, H. E., & Skevaki, C. L. (2018) · Allergo Journal · doi:10.1007/s15007-018-1580-4 · Cited by 13 · see citing works
Salmon, D. A., Dudley, M. Z., & Carleton, B. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa544 · Cited by 13 · see citing works
Guillain‐Barré syndrome after mRNA‐1273 (Moderna) COVID‐19 vaccination: A case report
Anjum, Z., Iyer, C., Naz, S., Jaiswal, V., Nepal, G., Laguio-Vila, M. R., Anandaram, S., & Thapaliya, S. (2022) · Clinical Case Reports · doi:10.1002/ccr3.5733 · Cited by 12 · see citing works
Risk of Guillain-Barré Syndrome Among Older Adults Receiving Influenza Vaccine in Taiwan
Yen, C.-C., Wei, K., Wang, W.-H., Huang, Y., & Chang, Y.-C. (2022) · JAMA Network Open · doi:10.1001/jamanetworkopen.2022.32571 · Cited by 12 · see citing works
Gulllain-Barre Syndrome After Trivalent Influenza Vaccination in Adults
Chang, K., Lyu, R., Lin, W., Huang, Y., Lin, H.-S., & Chang, S. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00768 · Cited by 12 · see citing works
McQuaid, C., Solorzano, A. G., Dickerson, I. M., & Deane, R. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1117845 · Cited by 12 · see citing works
Neurologic Safety Monitoring of COVID-19 Vaccines
Thakur, K. T., Epstein, S., Bilski, A. E., Balbi, A. M., Boehme, A. K., Brannagan, T. H., Wesley, S. F., & Riley, C. (2021) · Neurology · doi:10.1212/wnl.0000000000012703 · Cited by 11 · see citing works
Gatti, M., Raschi, E., Moretti, U., Ardizzoni, A., Poluzzi, E., & Diemberger, I. (2021) · Vaccines · doi:10.3390/vaccines9010019 · Cited by 11 · see citing works
Sağlık Öğrencilerinde Aşı Tereddüdü
Çetin, A. O., ŞAŞMAZ, A., Kurtulus, D., Badur, İ., Balkan, İ. İ., Owiwi, M., Öge, A., Atak, M., ALTUNEL, A., Akkoyun, M., et al. (2021) · Anadolu Kliniği Tıp Bilimleri Dergisi · doi:10.21673/anadoluklin.831919 · Cited by 11 · see citing works
Autoimmune/inflammatory syndrome induced by adjuvants
Radenska-Lopovok, S. G., & Volkova, P. (2018) · Russian Journal of Archive of Pathology · doi:10.17116/patol20188005156 · Cited by 11 · see citing works
Stoian, A. (2020) · FARMACIA · doi:10.31925/farmacia.2020.3.7 · Cited by 10 · see citing works
Fens, T., de Boer, P. T., van Puijenbroek, E., & Postma, M. J. (2021) · Vaccines · doi:10.3390/vaccines9020111 · Cited by 10 · see citing works
Cauchi, M., Ball, H. A., Ben‐Shlomo, Y., & Robertson, N. P. (2021) · Journal of Neurology · doi:10.1007/s00415-021-10747-8 · Cited by 10 · see citing works
Can Vaccination Trigger Autoimmune Disorders? A Meta-Analysis
Petráš, M., Lesná, I. K., Dáňová, J., & Čelko, A. M. (2021) · Vaccines · doi:10.3390/vaccines9080821 · Cited by 10 · see citing works
Pachas, P. E., Donaires, F., Gavilán, R. G., Quino, W., Vidal, M., Cabezas, C., García, M., Huaringa, M., Peceros, F. D. M., Valdivia, F., et al. (2020) · Revista Peruana de Medicina Experimental y Salud Pública · doi:10.17843/rpmesp.2020.374.5169 · Cited by 10 · see citing works
Goedee, H. S., Attarian, S., Küntzer, T., den Bergh, P. Y. K. V., & Rajabally, Y. A. (2021) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2019-321663 · Cited by 10 · see citing works
RSV vaccines and Guillain-Barré syndrome: Insights into an emerging concern
Anastassopoulou, C. G., Panagiotopoulos, A.-P., Ferous, S., Poland, G. A., Dodick, D. W., & Tsakris, A. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127338 · Cited by 9 · see citing works
Incidence of Guillain-Barré Syndrome Is Not Associated with Influenza Vaccination in the Elderly
Lee, H., Kang, H.-Y., Jung, S. Y., & Lee, Y. (2020) · Vaccines · doi:10.3390/vaccines8030431 · Cited by 9 · see citing works
Wang, F., Wang, D., Wang, Y., Li, C., Zheng, Y., Guo, Z., Liu, P., Zhang, Y., Wang, W., Wang, Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.782198 · Cited by 9 · see citing works
Guillain-Barre syndrome should be monitored upon mass vaccination against SARS-CoV-2
Leung, C. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1922061 · Cited by 9 · see citing works
Stowe, J., Watson, C., Ramsay, M. E., & Andrews, N. J. (2025) · Nature Communications · doi:10.1038/s41467-025-66280-z · Cited by 8 · see citing works
Treanor, J. J. (2023) · Springer eBooks · doi:10.1007/978-1-4939-9544-8_19-2 · Cited by 8 · see citing works
The need for novel influenza vaccines in low- and middle-income countries: A narrative review
Spinardi, J., Thakkar, K. B., Welch, V. L. L., Jagun, O., & Kyaw, M. H. (2024) · The Brazilian Journal of Infectious Diseases · doi:10.1016/j.bjid.2024.104465 · Cited by 8 · see citing works
Influenza Vaccination-associated Acute Thrombocytopenia and Diffuse Alveolar Hemorrhage
Yamamoto, Y., Ohara, Y., Iwai, A., Hara, R., Matsuki, T., Fukushima, K., Oshitani, Y., Kagawa, H., Tsujino, K., Yoshimura, K., et al. (2020) · Internal Medicine · doi:10.2169/internalmedicine.3991-19 · Cited by 8 · see citing works
Lee, H., Kim, H. J., Choe, Y. J., & Shin, J. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.06.038 · Cited by 8 · see citing works
Wang, Z., Li, X., Zheng, J., & He, Y. O. (2025) · Journal of Biomedical Semantics · doi:10.1186/s13326-025-00331-8 · Cited by 7 · see citing works
Anschau, L. C. K., Bortuluzi, A. M. M., Santos, A. D. S., Santos, D. D. S., Rodrigues, S. D. S., Machado, I. R., Kfouri, R. D. Á., Sáfadi, M. A. P., de Oliveira, R. D., & Croda, J. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70674 · Cited by 6 · see citing works
Autoimmune neuropathies: New guidelines and expert insights into clinical decision making
van Doorn, P. A., Sommer, C., & Rajabally, Y. A. (2025) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2025.125659 · Cited by 6 · see citing works
Adverse Events Following Vaccines: From Detection to Research Translation
Fernandez, E., Jaggers, J. L., Norton, A. E., Stone, C. A., & Phillips, E. J. (2024) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-071723-102841 · Cited by 6 · see citing works
Soni, R., Heindl, S. E., Wiltshire, D. A., Vahora, I. S., & Khan, S. (2020) · Cureus · doi:10.7759/cureus.10208 · Cited by 6 · see citing works
There Is No Evidence That Inactivated COVID-19 Vaccines Increase Risks of Uveitis Flare
Song, H., Zhao, C., & Zhang, M. (2022) · Vaccines · doi:10.3390/vaccines10101680 · Cited by 6 · see citing works
Roy, B., Litchman, T., Torabi, T., & Nowak, R. J. (2021) · Muscle & Nerve · doi:10.1002/mus.27224 · Cited by 6 · see citing works
Multifocal motor neuropathy after SARS-CoV-2 vaccination: a causal or coincidental association?
Eren, F., Aygül, R., Tenekeci, S., & Öztürk, Ş. (2022) · Journal of International Medical Research · doi:10.1177/03000605221110709 · Cited by 6 · see citing works
Patients' attitude towards vaccination after Guillain Barré syndrome
Holtz, B., Grimm, A. M., & Axer, H. (2021) · Health Science Reports · doi:10.1002/hsr2.469 · Cited by 6 · see citing works
Guillain-Barré Syndrome and Variants
Davalos, L., Kissel, J. T., Barohn, R. J., & Dimachkie, M. M. (2025) · Neurologic Clinics · doi:10.1016/j.ncl.2025.05.011 · Cited by 5 · see citing works
Schraad, M., Mäurer, M., Salmen, A., Ruck, T., Uphaus, T., Fleischer, V., Luessi, F., Protopapa, M., Steffen, F., Hanuscheck, N., et al. (2025) · Therapeutic Advances in Neurological Disorders · doi:10.1177/17562864251396006 · Cited by 5 · see citing works
Pan, M., Sun, T., Zhu, W., Liu, H., & Dong, H. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2261199 · Cited by 5 · see citing works
Guillain-Barré Syndrome after COVID-19 Vaccine: Should We Assume a Causal Link?
Kohli, S., Varshney, M., Mangla, S., Jaiswal, B., & Chhabra, P. H. (2021) · International Journal of Medical and Pharmaceutical Case Reports · doi:10.9734/ijmpcr/2021/v14i130124 · Cited by 5 · see citing works
Maunula, L. (2017) · TSpace (University of Toronto) · Cited by 5 · see citing works
Hadhiah, K. M., Alhashim, A., Al-Dandan, H. A., Alhassan, E., Alqarni, A. M., Memish, A. A. A., & Alabdali, M. M. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1332364 · Cited by 4 · see citing works
Lighting Strikes Twice: Recurrent Guillain–Barré Syndrome (GBS) after Influenza Vaccination
Griffin, G. D., Cunningham, B., Beary, J. M., Spolter, Y. S., Gandee, R., & Newey, C. R. (2021) · Case Reports in Neurological Medicine · doi:10.1155/2021/6690643 · Cited by 4 · see citing works
Mosná, K., Vadkerti, P., Papp, L., Palkovič, M., Janega, P., & Babál, P. (2022) · The Open Neurology Journal · doi:10.2174/1874205x-v16-e2207270 · Cited by 4 · see citing works
Pharmacoepidemiologic Studies of Vaccine Safety
Chen, R. T., Glanz, J. M., & Shimabukuro, T. T. (2019) · Pharmacoepidemiology · doi:10.1002/9781119413431.ch20 · Cited by 4 · see citing works
Wang, Z., Wu, S., Li, X., Hu, R., Yu, J., Xu, B., Zhu, Y., & Liu, P. (2025) · Vaccines · doi:10.3390/vaccines13111154 · Cited by 3 · see citing works
Ferreira, S. D. C., Vasconcelos, J. R. D. O., Rezende, R. E. F., Aprile, L. R. O., & Troncon, L. E. D. A. (2024) · American Journal of Case Reports · doi:10.12659/ajcr.943709 · Cited by 3 · see citing works
Vaccination in pediatric acquired inflammatory immune-mediated neuromuscular disorders
Barišić, N., Turudić, D., Marić, L. S., & Tešović, G. (2021) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2021.12.014 · Cited by 3 · see citing works
- Authors
- Martín Arias, L. H., Sanz, R., Sáinz, M., Treceño, C., & Carvajal, A.
- Affiliations
- Universidad de Valladolid (ES)
- Corresponding author
- Carvajal, A.
- ORCID
- Carvajal, A.
- Venue
- Vaccine
- Publisher
- Elsevier BV
- Published
- 2015-07
- Volume
- 33
- Issue
- 31
- Pages
- 3773-3778
- ISSN
- 0264-410X (ISSN-L)
- OpenAlex
- W324672716
- Cited by
- 132
- References
- 54
- Citations by year
- 2026: 7 · 2025: 12 · 2024: 11 · 2023: 11 · 2022: 15 · 2021: 28 · 2020: 13 · 2019: 11 · 2018: 10 · 2017: 8 · 2016: 6
- FWCI
- 1.05
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Vaccine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
- Keywords
- Guillain-Barré syndrome, influenza vaccination, vaccine adverse events, pandemic influenza vaccine, seasonal influenza vaccine, adjuvanted vaccine, relative risk, vaccine safety
- MeSH terms
- Influenza Vaccines, Guillain-Barre Syndrome, Observational Studies as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
